BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fishman P, Cohen S, Itzhak I, Amer J, Salhab A, Barer F, Safadi R. The A3 adenosine receptor agonist, namodenoson, ameliorates non‑alcoholic steatohepatitis in mice. Int J Mol Med 2019;44:2256-64. [PMID: 31638172 DOI: 10.3892/ijmm.2019.4364] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Qian X, Wang T, Gong J, Wang L, Chen X, Lin H, Tu W, Jiang S, Li S. Exercise in mice ameliorates high-fat diet-induced nonalcoholic fatty liver disease by lowering HMGCS2. Aging (Albany NY) 2021;13:8960-74. [PMID: 33647884 DOI: 10.18632/aging.202717] [Reference Citation Analysis]
2 Salmaso V, Jacobson KA. Purinergic Signaling: Impact of GPCR Structures on Rational Drug Design. ChemMedChem 2020;15:1958-73. [PMID: 32803849 DOI: 10.1002/cmdc.202000465] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
3 Suresh RR, Jain S, Chen Z, Tosh DK, Ma Y, Podszun MC, Rotman Y, Salvemini D, Jacobson KA. Design and in vivo activity of A3 adenosine receptor agonist prodrugs. Purinergic Signal 2020;16:367-77. [PMID: 32720036 DOI: 10.1007/s11302-020-09715-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
4 Suresh RR, Gao ZG, Salmaso V, Chen E, Campbell RG, Poe RB, Liston TE, Jacobson KA. Selective A3 Adenosine Receptor Antagonist Radioligand for Human and Rodent Species. ACS Med Chem Lett 2022;13:623-31. [PMID: 35450351 DOI: 10.1021/acsmedchemlett.1c00685] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Muñoz-Cano R, San Bartolome C, Casas-Saucedo R, Araujo G, Gelis S, Ruano-Zaragoza M, Roca-Ferrer J, Palomares F, Martin M, Bartra J, Pascal M. Immune-Mediated Mechanisms in Cofactor-Dependent Food Allergy and Anaphylaxis: Effect of Cofactors in Basophils and Mast Cells. Front Immunol 2020;11:623071. [PMID: 33679712 DOI: 10.3389/fimmu.2020.623071] [Reference Citation Analysis]
6 Li J, Yan H, Xiang R, Yang W, Ye J, Yin R, Yang J, Chi Y. ATP Secretion and Metabolism in Regulating Pancreatic Beta Cell Functions and Hepatic Glycolipid Metabolism. Front Physiol 2022;13:918042. [DOI: 10.3389/fphys.2022.918042] [Reference Citation Analysis]
7 Eslami Z, Mirghani SJ, Eghbal Moghanlou A, Norouzi A, Naseh H, Joshaghani H, Ferreira Peres WA, Younesian O, Hosseinzadeh S, Azari Bideskan J. An Efficient Model of Non-alcoholic Fatty Liver Disease (NAFLD) Versus Current Experimental Models: Effects of Fructose, Fat, and Carbon Tetrachloride on NAFLD. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.117696] [Reference Citation Analysis]
8 Kimura T, Singh S, Tanaka N, Umemura T. Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease. Front Endocrinol (Lausanne) 2021;12:773432. [PMID: 34938271 DOI: 10.3389/fendo.2021.773432] [Reference Citation Analysis]
9 Jain S, Jacobson KA. Purinergic signaling in diabetes and metabolism. Biochem Pharmacol 2021;187:114393. [PMID: 33359363 DOI: 10.1016/j.bcp.2020.114393] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Tosh DK, Salmaso V, Rao H, Campbell R, Bitant A, Gao ZG, Auchampach JA, Jacobson KA. Direct Comparison of (N)-Methanocarba and Ribose-Containing 2-Arylalkynyladenosine Derivatives as A3 Receptor Agonists. ACS Med Chem Lett 2020;11:1935-41. [PMID: 33062176 DOI: 10.1021/acsmedchemlett.9b00637] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
11 Jain S, Jacobson KA. Purinergic Signaling in Liver Pathophysiology. Front Endocrinol (Lausanne) 2021;12:718429. [PMID: 34456873 DOI: 10.3389/fendo.2021.718429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]